Brainsway Ltd - ADR
BWAY
Market Cap$158.71M
Close$
$-6.05
172.6% downside
Current Fair Value
172.6% downsideOvervalued by 172.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $158.71 Million |
|---|---|
| Enterprise Value | $115.41 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.09 |
| Beta | 0.16 |
| Outstanding Shares | 38,700,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 84.26 |
|---|---|
| PEG | -21.73 |
| Price to Sales | - |
| Price to Book Ratio | 8.34 |
| Enterprise Value to Revenue | 2.99 |
| Enterprise Value to EBIT | 58.47 |
| Enterprise Value to Net Income | 76 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Brainsway Ltd.
CEO: Christopher von Jako Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the tr...